Psychopathology

Letter to the Editor

Free Access

The Impact of Consanguinity on Risk of Schizophrenia

Bener A.a,c,d · Dafeeah E.E.b · Samson N.a, c

Author affiliations

aDepartment of Medical Statistics and Epidemiology, Hamad General Hospital, and bDepartment of Psychiatry, Rumeilah Hospital, Hamad Medical Corporation, and cDepartment of Public Health, Weill Cornell Medical College, Doha, Qatar; dDepartment Evidence for Population Health Unit, School of Epidemiology and Health Sciences, University of Manchester, Manchester, UK

Corresponding Author

Prof. Abdulbari Bener

Department of Medical Statistics and Epidemiology

Hamad Medical Corporation and Weill Cornell Medical College

PO Box 3050, Doha (Qatar)

Tel. +974 439 3765/3766, E-Mail abener@hmc.org.qa

Related Articles for ""

Psychopathology 2012;45:399–400

Schizophrenia (Sz) occurs worldwide and is one of the severest mental disorders [1]. The World Health Organization documented that Sz has been recognized as a major public health problem in the fourth position among the global burden of diseases [2]. It has been generally accepted that Sz, like all other complex diseases, is caused by genetic and environmental factors. Bener et al. [3] reported that consanguinity (inbreeding) may be associated with an increased risk for a wide range of genetically complex disorders. Marriages between relatives are common worldwide and lead to human consanguinity. It was found that consanguineous marriages increase the risk for Sz in offspring [4]. Since consanguinity is widely practiced in the Eastern Mediterranean region, it was considered worthwhile to study this aspect in this population. Moreover, an elevated parental consanguinity rate of 52% was reported in the State of Qatar [3].

The aim of the study was to examine the impact of consanguinity on the risk for Sz disorders and investigate the inbreeding characteristics of the Sz patients.

Methods

The cross-sectional study was based on the Primary Health Care Centers among Arab patients aged 18–55 years from January 2009 to December 2010. Of the sample size of 1,491 subjects, 1,184 patients agreed to participate in this study (79.4%). Institutional review board approval was obtained from the Hamad Medical Corporation for conducting this research. The subjects who did not agree to participate (20.6%) were demographically similar to those who had agreed to participate. A validated self-administered questionnaire was designed to collect the data based on face-to-face interviews by physicians and qualified nurses. Following completion of this questionnaire by the patient, the provisional diagnosis score was calculated from the responses, which was then confirmed by psychiatrists through a clinical questioning using DSM-IV criteria. The general diagnostic screening questionnaire was not designed to make a definitive diagnosis but rather to identify people at high risk. Content validity, face validity and reliability of the questionnaire were tested using 50 patients. These tests demonstrated a high level of validity and high degree of repeatability (ĸ = 0.84) and Cronbach’s α-coefficient was 0.82.

Student t test, nonparametric Mann-Whitney test, χ2 and Fisher’s exact tests (two-tailed) were performed for statistical analysis. The Student t test was used to determine the mean and standard deviation of the coefficient of inbreeding of the two groups. p < 0.05 was considered as the cutoff value for significance.

Results

The data reveals the genetic factors of the studied subjects with or without Sz. Parental consanguinity was elevated among the patients with Sz (43.8%) with a higher mean coefficient of inbreeding (0.0198 ± 0.29) than in non-Sz subjects (38%) with a lower mean inbreeding coefficient (0.0151 ± 0.24). Similarly, the inbreeding coefficient was higher in schizophrenic male (0.01857 ± 0.027 vs. 0.0145 ± 0.024) and female (0.0208 ± 0.030 vs. 0.0158 ± 0.024) patients compared to their counterparts.

Discussion

The present study has described the association of consanguinity and Sz in the Arab population of Qatar. The most important finding was that there is an increased morbidity of Sz in the first-degree relatives of Sz patients (26.8%) compared to the controls (19.8%). Dobrusin et al. [4] reported a tenfold greater risk in first-degree biological relatives of Sz patients than in the normal population. The rate of parental consanguinity (43.8 vs. 38%) and the mean coefficient of inbreeding (0.0198 ± 0.29 vs. 0.015 ± 0.24) was higher among Sz patients compared to subjects without Sz (table 1). Similar to our results, a significant elevated rate of consanguinity was observed among Sz patients in Egypt [5]. The present study has confirmed that consanguinity contributes to a high incidence of Sz in offspring. The most striking difference in the occurrence of Sz was that familial transmission of Sz was greater among female probands (57.1%; 0.04592) with a higher mean inbreeding coefficient than in the male probands (42.9%; 0.03947) which is in line with the study results of Goldstein et al. [6]. Also, a positive family history of Sz was associated with the occurrence of Sz in parents (24.6%; p = 0.04), grandparents (17.5%; p = 0.03) and aunts (21.4%; p = 0.002). Even, family studies confirmed that relatives of probands with Sz have an increased risk of developing Sz. Family members share a common culture and a common environment; hence familial environmental factors may confound genetic relationships.

Table 1

Genetic factors of the studied subjects with or without Sz (n = 1,184)

http://www.karger.com/WebMaterial/ShowPic/203317

In conclusion, our study revealed that the parental consanguinity and family history are the main risk factors for the development of Sz among an Arab population. The inbreeding coefficient was significantly elevated among Arab Sz patients compared to an Arab population without Sz.



Related Articles:


References

  1. Schultz SK, Andreasen NC: Schizophrenia. Lancet 1999;353:1425–1430.
  2. WHO International Consortium in Psychiatric Epidemiology: Cross-national comparisons of the prevalence and correlates of mental disorders. Bull World Health Organization 2000;78:413–426.
  3. Bener A, Hussain R, Teebi AS: Consanguineous marriages and their effects on diseases: studies from an endogamous population. Med Princ Pract 2007;16:262–267.
  4. Dobrusin M, Weitzman D, Levine J, Kremer L, Rietschel M, Maier W, Belmaker R: The rate of consanguineous marriages among parents of schizophrenic patients in the Arab bedouin population in southern Israel. World J Biol Psychiatry 2009;10:334–336.
    External Resources
  5. Mansour H, Fathi W, Klei L, Wood J, Chowdari K, Watson A, Eissa A, Elassy M, Ali I, Salah H, Yassin A, Tobar S, El-Boraie H: Consanguinity and increased risk for schizophrenia in Egypt. Schizophrenia Res 2010;120:108–112.
    External Resources
  6. Goldstein JM, Faraone SV, Chen WJ, Tolomiczencko GS, Tsuang MT: Sex differences in the familial transmission of schizophrenia. Br J Psychiatry 1990;156:819–826.

Author Contacts

Prof. Abdulbari Bener

Department of Medical Statistics and Epidemiology

Hamad Medical Corporation and Weill Cornell Medical College

PO Box 3050, Doha (Qatar)

Tel. +974 439 3765/3766, E-Mail abener@hmc.org.qa


Article / Publication Details

Received: May 25, 2011
Accepted: April 08, 2012
Published online: August 07, 2012
Issue release date: October 2012

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 1

ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)

For additional information: https://www.karger.com/PSP


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Schultz SK, Andreasen NC: Schizophrenia. Lancet 1999;353:1425–1430.
  2. WHO International Consortium in Psychiatric Epidemiology: Cross-national comparisons of the prevalence and correlates of mental disorders. Bull World Health Organization 2000;78:413–426.
  3. Bener A, Hussain R, Teebi AS: Consanguineous marriages and their effects on diseases: studies from an endogamous population. Med Princ Pract 2007;16:262–267.
  4. Dobrusin M, Weitzman D, Levine J, Kremer L, Rietschel M, Maier W, Belmaker R: The rate of consanguineous marriages among parents of schizophrenic patients in the Arab bedouin population in southern Israel. World J Biol Psychiatry 2009;10:334–336.
    External Resources
  5. Mansour H, Fathi W, Klei L, Wood J, Chowdari K, Watson A, Eissa A, Elassy M, Ali I, Salah H, Yassin A, Tobar S, El-Boraie H: Consanguinity and increased risk for schizophrenia in Egypt. Schizophrenia Res 2010;120:108–112.
    External Resources
  6. Goldstein JM, Faraone SV, Chen WJ, Tolomiczencko GS, Tsuang MT: Sex differences in the familial transmission of schizophrenia. Br J Psychiatry 1990;156:819–826.
Tables
Thumbnail
TOP